- Home
- GOSS vs VTIX Comparison
GOSS vs VTIX Comparison
Compare GOSS & VTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | VTIX |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.8M | 83.9M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GOSS | VTIX |
|---|---|---|
| Price | $9.32 | $0.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $95.40 | $8.50 |
| AVG Volume (30 Days) | ★ 289.5K | 230.2K |
| Earning Date | 11-04-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.99 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $48,471,000.00 | $4,252,643.00 |
| Revenue This Year | N/A | $18.40 |
| Revenue Next Year | N/A | $267.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 18.44 |
| 52 Week Low | $0.11 | $0.92 |
| 52 Week High | $12.52 | $9.00 |
Technical Indicators
Market Signals| Indicator | GOSS | VTIX |
|---|---|---|
| Relative Strength Index (RSI) | 55.54 | 26.26 |
| Support Level | $0.18 | N/A |
| Resistance Level | $12.49 | $1.26 |
| Average True Range (ATR) | 0.84 | 0.08 |
| MACD | -0.58 | -0.01 |
| Stochastic Oscillator | 10.66 | 0.00 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
About VTIX Virtuix Holdings Inc. Class A Common Stock
Virtuix Holdings Inc pioneers movement in AI-generated worlds, both imaginary and real. The company is the creator of Omni, a brand of omni-directional treadmills that enable users to walk and run in 360 degrees inside virtual reality (VR) games, digital twins, and other applications. Its technology operates at the intersection of gaming, fitness, and enterprise VR. Its products include Omni Pro, Omni Arena, and Omni One. Its business integrates a consumer and enterprise VR hardware platform anchored by its flagship Omni One product with a defense-oriented simulation system, Virtual Terrain Walk (VTW), targeting next-generation immersive mission planning.